Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20200723048182N1Phase 3Completed
Phase 3, double-blind trial of captopril and carvedilol in hypertension (HTN) (2 arms), sponsored by Islamic Azad University. Primary endpoints: Systolic blood pressure, Diastolic blood pressure and 3 more. Started Sep 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20200723048182N1.